NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Gary, I can't answer you as to whether DCVax could eventually treat blood borne cancers, but I do believe that there has been promising work done using dendritic cells, so I'd imagine that the company would ultimately like to approach treating these cancers as well.

What I can say about DCVax-Direct is that every time it's injected, it's basically creating a new vaccine at that very spot it's injected into the tumor. So I don't think they should create a limited number of months supply, because the personalized vaccine doesn't contain any of the tumor, as it doesn't come into contact with the tumor until it's injected into one. And the same vaccine can then be injected into a second tumor in the same person, and each time that's done, it becomes a personalized vaccine for the next tumor, just as it was a personalized for the initial tumor.